academic.oup.com/jes/article/9/ GLP-1 in addiction medicine: GLP-1 acts on pancreas, gut, kidney, heart and thyroid receptors to activate reward/stress hubs (VTA, NAc, ARC, PFC, hypothalamus)
442 Studies have shown that once-daily (2 g1) or twice-daily (1 g2) dosing is associated with 69% or 61% clinical and endoscopic remission rates, respectively
The figures were created with the assistance of Figdraw ( Ethics declarations Competing interests The authors declare no competing interests
Read the full executive interpretation Importantly, the best available comparative real-world evidence located during this review does not suggest an increased risk of vulvovaginal infections with semaglutide
Los GLP-1 benefician la salud del corazn Adems de ayudar a mejorar el manejo de la diabetes tipo 2, los GLP-1 pueden beneficiar a los pacientes con problemas de salud cardiovascular o en riesgo de padecerlos